CDTi to Supply Advanced Materials Technology to India’s Fast-Growing Automotive Market
Sep 27, 2016 12:01 pm UTC| Business
- Establishes strategic partnership with Süd-Chemie India to commercialize BMARS™, MPC® and SPGM™ technologies -- Supply Agreement concluded - - CDTI expands to new geographic region in Asia - - Advancing powder-to-coat...
CDTi to Supply Advanced Materials Technology to India’s Fast-Growing Automotive Market
Sep 27, 2016 12:01 pm UTC| Business
- Establishes strategic partnership with Süd-Chemie India to commercialize BMARS™, MPC® and SPGM™ technologies -- Supply Agreement concluded - - CDTI expands to new geographic region in Asia - - Advancing powder-to-coat...
Sep 27, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Sept. 27, 2016 -- Momenta Pharmaceuticals, Inc.(NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Shire has exercised its...
Sep 27, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Sept. 27, 2016 -- Momenta Pharmaceuticals, Inc.(NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Shire has exercised its...
Insmed Appoints Roger Adsett as Chief Commercial Officer
Sep 27, 2016 12:01 pm UTC| Business
BRIDGEWATER, N.J., Sept. 27, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the appointment of Roger Adsett as...
Insmed Appoints Roger Adsett as Chief Commercial Officer
Sep 27, 2016 12:01 pm UTC| Business
BRIDGEWATER, N.J., Sept. 27, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the appointment of Roger Adsett as...
Coherus BioSciences Regains Development and Commercial Rights to CHS-0214 From Shire
Sep 27, 2016 12:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 27, 2016 -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced that it has regained from Shire plc all development and commercial rights previously licensed for CHS-0214 etanercept, a...